ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Nutrition Weakness Hits DSM’s Rating

by Alex Scott
November 30, 2015 | APPEARED IN VOLUME 93, ISSUE 47

Moody’s Investor Services has downgraded DSM’s credit rating from stable to negative on account of a “significant squeeze” in profitability for the firm’s nutrition business. The change in rating could make it more expensive for DSM to borrow money. A turnaround for the business is unlikely in the medium term, Moody’s states, in part because of growing Chinese competition. Pre-tax profits for the nutrition division dropped 5% to $227 million in the third quarter compared with the year-earlier period, despite a 15% hike in sales to $1.3 billion. DSM’s overall profits increased 2% to $305 million in the quarter on an 8% jump in sales to $2.1 billion.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment